ID BV-173 AC CVCL_0181 SY BV173 DR BTO; BTO_0004950 DR CLO; CLO_0002052 DR EFO; EFO_0002118 DR MCCL; MCC:0000072 DR CLDB; cl510 DR CLDB; cl4968 DR ArrayExpress; E-MTAB-38 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-2770 DR ArrayExpress; E-MTAB-3610 DR ArrayExpress; E-MTAB-7721 DR ArrayExpress; E-MTAB-7722 DR BioSample; SAMN03473373 DR BioSample; SAMN10988488 DR cancercelllines; CVCL_0181 DR CCTCC; GDC0607 DR Cell_Model_Passport; SIDM00962 DR ChEMBL-Cells; CHEMBL3308228 DR ChEMBL-Targets; CHEMBL2366145 DR CLS; 300133 DR Cosmic; 798672 DR Cosmic; 910710 DR Cosmic; 922164 DR Cosmic; 994184 DR Cosmic; 996292 DR Cosmic; 998702 DR Cosmic; 999741 DR Cosmic; 1019833 DR Cosmic; 1026570 DR Cosmic; 1037734 DR Cosmic; 1070701 DR Cosmic; 1071881 DR Cosmic; 1127249 DR Cosmic; 1176600 DR Cosmic; 1191703 DR Cosmic; 1524792 DR Cosmic-CLP; 910710 DR DepMap; ACH-000432 DR DSMZ; ACC-20 DR DSMZCellDive; ACC-20 DR EGA; EGAS00001000978 DR GDSC; 910710 DR GEO; GSM236779 DR GEO; GSM236815 DR GEO; GSM886895 DR GEO; GSM887960 DR GEO; GSM1374414 DR GEO; GSM1669633 DR IARC_TP53; 21199 DR ICLC; HTL99018 DR IGRhCellID; BV173 DR LiGeA; CCLE_631 DR LINCS_LDP; LCL-1111 DR Lonza; 117 DR PharmacoDB; BV173_148_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_0181 DR PubChem_Cell_line; CVCL_0181 DR Wikidata; Q54798653 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=1720549; RX PubMed=3098690; RX PubMed=3332852; RX PubMed=3856862; RX PubMed=6572735; RX PubMed=9680106; RX PubMed=10071072; RX PubMed=10576511; RX PubMed=14504097; RX PubMed=16523483; RX PubMed=20164919; RX PubMed=20215515; RX PubMed=20809971; RX PubMed=22460905; RX PubMed=26589293; RX PubMed=27397505; RX PubMed=30285677; RX PubMed=30629668; RX PubMed=30894373; RX PubMed=31068700; RX PubMed=31160637; RX PubMed=35839778; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Part of: LL-100 blood cancer cell line panel. CC Population: Caucasian. CC Doubling time: 30-35 hours (PubMed=6572735); ~48 hours (DSMZ=ACC-20). CC HLA typing: A*02:01,30:01; B*15:10,18:01; C*03:04,12:03 (PubMed=26589293). CC HLA typing: A*02:01:01,30:01:01; B*15:10:01,18:01:01; C*03:04:02,12:03:01; DPA1*01:03:01,02:01:02; DPB1*02:01:02,01:01:01; DQA1*01:02:01,01:02:02; DQB1*05:02:01,06:03:01; DRA*01:01:01,01:02:02; DRB1*13:02:01,16:01:01 (DSMZCellDive=ACC-20). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=20809971; DepMap=ACH-000432). CC Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln4045Ter (c.12133C>T); Zygosity=Heterozygous (Cosmic-CLP=910710; DepMap=ACH-000432). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; Array-based CGH. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=1.38%; Native American=0%; East Asian, North=2.14%; East Asian, South=0%; South Asian=2.51%; European, North=52.2%; European, South=41.77% (PubMed=30894373). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. ST Source(s): CLS=300133; Cosmic-CLP=910710; DSMZ=ACC-20 ST Amelogenin: X ST CSF1PO: 11,12 ST D13S317: 8,10 ST D16S539: 11,13 ST D18S51: 12,16 ST D19S433: 13 ST D21S11: 30,32 ST D2S1338: 24,25 ST D3S1358: 16,17 ST D5S818: 10,12 ST D7S820: 10,11 ST D8S1179: 11,12,13 (CLS=300133) ST D8S1179: 12,13 (DSMZ=ACC-20) ST FGA: 20,24 ST Penta D: 11 ST Penta E: 12,16 ST TH01: 6,9.3 ST TPOX: 8,10 ST vWA: 16 DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive DI ORDO; Orphanet_521; Chronic myeloid leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 45Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 46 CH CVCL_5K95 ! BV-173/E255K // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=1720549; DOI=10.1073/pnas.88.23.10735; PMCID=PMC53005; RA Ziemin-van der Poel, Sheryl RA McCabe, Norah R. RA Gill, Heidi J. RA Espinosa, Rafael 3rd RA Patel, Yogesh RA Harden, Alanna M. RA Rubinelli, Peter Marius RA Smith, Stephen D. RA Le Beau, Michelle M. RA Rowley, Janet Davison RA Diaz, Manuel O. RT "Identification of a gene, MLL, that spans the breakpoint in 11q23 RT translocations associated with human leukemias."; RL Proc. Natl. Acad. Sci. U.S.A. 88:10735-10739(1991). // RX PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646; RA Quentmeier, Hilmar RA Pommerenke, Claudia RA Dirks, Wilhelm Gerhard RA Eberth, Sonja RA Koeppel, Max RA MacLeod, Roderick A.F. RA Nagel, Stefan RA Steube, Klaus G. RA Uphoff, Cord C. RA Drexler, Hans Gunther RT "The LL-100 panel: 100 cell lines for blood cancer studies."; RL Sci. Rep. 9:8218.1-8218.14(2019). // RX PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4; RA Drexler, Hans Gunther RA MacLeod, Roderick A.F. RA Uphoff, Cord C. RT "Leukemia cell lines: in vitro models for the study of Philadelphia RT chromosome-positive leukemia."; RL Leuk. Res. 23:207-215(1999). // RX PubMed=6572735; RA Pegoraro, Luigi RA Matera, Lina RA Ritz, Jerome RA Levis, Alessandro RA Palumbo, Antonio RA Biagini, Graziella RT "Establishment of a Ph1-positive human cell line (BV173)."; RL J. Natl. Cancer Inst. 70:447-453(1983). // RX PubMed=14504097; DOI=10.1182/blood-2003-02-0418; RA Taketani, Takeshi RA Taki, Tomohiko RA Sugita, Kanji RA Furuichi, Yoshiyuki RA Ishii, Eiichi RA Hanada, Ryoji RA Tsuchida, Masahiro RA Sugita, Kenichi RA Ida, Kohmei RA Hayashi, Yasuhide RT "FLT3 mutations in the activation loop of tyrosine kinase domain are RT frequently found in infant ALL with MLL rearrangements and pediatric RT ALL with hyperdiploidy."; RL Blood 103:1085-1088(2004). // RX PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2; RA Matsuo, Yoshinobu RA Drexler, Hans Gunther RT "Establishment and characterization of human B cell precursor-leukemia RT cell lines."; RL Leuk. Res. 22:567-579(1998). // RX PubMed=10576511; DOI=10.1016/S0145-2126(99)00131-9; RA Uphoff, Cord C. RA Habig, Silke RA Fombonne, Severine RA Matsuo, Yoshinobu RA Drexler, Hans Gunther RT "ABL-BCR expression in BCR-ABL-positive human leukemia cell lines."; RL Leuk. Res. 23:1055-1060(1999). // RX PubMed=16523483; DOI=10.1002/gcc.20317; RA Horsley, Sharon W. RA Mackay, Alan RA Iravani, Marjan RA Fenwick, Kerry RA Valgeirsson, Haukur RA Dexter, Tim J. RA Ashworth, Alan RA Kearney, Lyndal RT "Array CGH of fusion gene-positive leukemia-derived cell lines reveals RT cryptic regions of genomic gain and loss."; RL Genes Chromosomes Cancer 45:554-564(2006). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786; RA Tan, Kar-Tong RA Ding, Ling-Wen RA Sun, Qiao-Yang RA Lao, Zhen-Tang RA Chien, Wenwen RA Ren, Xi RA Xiao, Jin-Fen RA Loh, Xin-Yi RA Xu, Liang RA Lill, Michael RA Mayakonda, Anand RA Lin, De-Chen RA Yang, Henry He RA Koeffler, Harold Phillip RT "Profiling the B/T cell receptor repertoire of lymphocyte derived cell RT lines."; RL BMC Cancer 18:940.1-940.13(2018). // RX PubMed=3856862; DOI=10.1073/pnas.82.6.1810; PMCID=PMC397362; RA Konopka, James B. RA Watanabe, Susan M. RA Singer, Jack W. RA Collins, Steven J. RA Witte, Owen Neil RT "Cell lines and clinical isolates derived from Ph1-positive chronic RT myelogenous leukemia patients express c-abl proteins with a common RT structural alteration."; RL Proc. Natl. Acad. Sci. U.S.A. 82:1810-1814(1985). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=30629668; DOI=10.1371/journal.pone.0210404; PMCID=PMC6328144; RA Uphoff, Cord C. RA Pommerenke, Claudia RA Denkmann, Sabine A. RA Drexler, Hans Gunther RT "Screening human cell lines for viral infections applying RNA-Seq data RT analysis."; RL PLoS ONE 14:e0210404.1-e0210404.22(2019). // RX PubMed=20809971; DOI=10.1186/1755-8166-3-15; PMCID=PMC2944125; RA Virgili, Anna RA Nacheva, Elisabeth RT "Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in RT chronic myeloid leukaemia: a FISH mapping study of CML patients and RT cell lines."; RL Mol. Cytogenet. 3:15.1-15.12(2010). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX PubMed=3098690; DOI=10.1002/ijc.2910390116; RA Th'ng, Kang Hock RA Garewal, Gurjivan RA Kearney, Lyndal RA Rassool, Feyruz V. RA Vaz de Melo, Junia RA White, H. RA Catovsky, Daniel RA Foroni, Letizia RA Luzzatto, Lucio RA Goldman, John Michael RT "Establishment and characterization of three new malignant lymphoid RT cell lines."; RL Int. J. Cancer 39:89-93(1987). // RX PubMed=3332852; DOI=10.1016/S0950-3536(87)80037-9; RA Keating, Armand RT "Ph positive CML cell lines."; RL Baillieres Clin. Haematol. 1:1021-1029(1987). //